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X chromosome inactivation (XCI) is a mechanism specifically initiated in
female cells to silence one X chromosome, thereby equalizing the dose of
X-linked gene products between male and female cells. XCI is regulated
by a locus on the X chromosome termed the X-inactivation centre (XIC).
Located within the XIC is XIST, which acts as a master regulator of XCI.
During XCI, XIST is upregulated on the inactive X chromosome and
chromosome-wide cis spreading of XIST leads to inactivation. In mouse,
the Xic comprises Xist and all cis-regulatory elements and genes involved
in Xist regulation. The activity of the XIC is regulated by trans-acting factors
located elsewhere in the genome: X-encoded XCI activators positively regu-
lating XCI, and autosomally encoded XCI inhibitors providing the threshold
for XCI initiation. Whether human XCI is regulated through a similar mech-
anism, involving trans-regulatory factors acting on the XIC has remained
elusive so far. Here, we describe a female individual with ovarian dysgenesis
and a small X chromosomal deletion of the XIC. SNP-array and targeted
locus amplification (TLA) analysis defined the deletion to a 1.28 megabase
region, including XIST and all elements and genes that perform cis-
regulatory functions in mouse XCI. Cells carrying this deletion still initiate
XCI on the unaffected X chromosome, indicating that XCI can be initiated
in the presence of only one XIC. Our results indicate that the trans-acting
factors required for XCI initiation are located outside the deletion, providing
evidence that the regulatory mechanisms of XCI are conserved between
mouse and human.
This article is part of the themed issue ‘X-chromosome inactivation: a
tribute to Mary Lyon’.1. Introduction
X chromosome inactivation (XCI) is a process that takes place in all female
somatic cells, and results in almost complete transcriptional silencing of one
of the X chromosomes. This process ensures that female XX cells have an
equal dosage of X-chromosomal gene products compared to male XY cells
[1]. XCI is initiated early during embryogenesis, where all cells of the female
embryo proper randomly initiate inactivation of either the paternal or the
maternal X chromosome. After the inactive state is established, the inactive X
(Xi) is clonally passed on to all daughter cells. As a result, all females are a
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cells with an active maternal X chromosome. The X inacti-
vation ratio (XIR) between cells carrying an active paternal
X chromosome and cells carrying an active maternal X
chromosome differs between female individuals. In a
female population the average XIR is 50 : 50, but ranges up
to 100 : 0, as a result of chance, genetic predisposition
or cell selection [2]. Within a female individual the XIR
correlates between tissues of different origin [3].
The genetic elements involved in regulating XCI have
been a subject of study for several decades. A region on the
X chromosome was identified to be required for XCI. In
human, this X inactivation centre (XIC) has been mapped
to a 680–1200 kb region at chromosome Xq13 [4–6], deduced
from several inversions and truncations involving the X
chromosome in different individuals.
The genes that constitute the XIC are conserved in euther-
ians, and have been mostly studied in mouse. In contrast to
the human XIC, the mouse Xic is less well defined and has
been mapped to a 10–20 Mb region on the X chromosome
[7,8]. Centrally located in the XIC/Xic is the long non-
coding RNA (lncRNA) XIST/Xist, which is essential for XCI
[9,10]. Initiation of XCI is characterized by XIST/Xist upregu-
lation on the future Xi, resulting in the cis spreading of XIST/
Xist RNA, which recruits chromatin remodelling complexes
that silence the X chromosome [11]. In mouse, several other
lncRNA genes located within the Xic are involved in regulat-
ing XCI, through co-activation and -repression mechanisms
acting to regulate Xist, predominantly in-cis [12–16]. Several
trans-acting X-encoded XCI activators ensure that XCI is
only initiated in the presence of two X chromosomes [17].
In mouse the RING finger protein 12 (Rnf12, also known as
RING finger LIM domain interacting protein Rlim) represents
the most prominent XCI activator [18,19]. Rnf12 encodes an
E3-ubiquitin ligase that targets REX1, a repressor of Xist,
for proteasomal degradation [20]. Only in cells with more
than one X chromosome present in the nucleus is the concen-
tration of RNF12 and other XCI activators high enough to
initiate XCI.
In human, the regulation of XCI is less clear. Although the
XIC has been localized, the requirement for trans-regulatory
mechanisms has not been studied. To examine whether XCI
in human is also regulated by trans-regulatory mechanisms
acting on the XIC, which contains all the cis-regulatory
elements to direct XIST expression, we have identified and
studied a female carrier with a deletion of the XIC.2. Results
A 26 year old, intellectually normal, non-dysmorphic woman
presented with primary amenorrhoea, and was diagnosed
with hypergonadotropic ovarian failure due to ovarian dys-
genesis, also known as premature ovarian insufficiency
(POI). Blood examination showed increased FSH levels
(more than 40 IU l21), with decreased oestrogen (less than
60 pmol l21). Height was between the 75th–90th centile and
no stigmata of Turner syndrome were evident on examin-
ation. External genitalia were unambiguously female. Breast
development, pubic and axillary hair distribution were
normal female at the time of examination following several
years of oral contraceptive hormone treatment. On transvagi-
nal ultrasound examination a small uterus was visible,measuring 1.9  0.9  1.4 cm3, with hypoplastic endo-
metrium of 0.1 mm. No clear ovarian tissue was identified;
however, an area of thickening without antral follicles
0.6 cm in length was seen in the left ovarian fossa and a simi-
lar region 1 cm in length, in the right ovarian fossa. karyotype
analysis of blood cells showed a normal 46XX karyotype.
DNA was isolated from peripheral blood and was used for
molecular SNP karyotyping, using the Human OmniEx-
press-24 SNP-array from Illumina. Several regions showing
loss of heterozygosity were identified, which might be
explained by a history of parental consanguinity. However,
only one single significant copy number change was ident-
ified corresponding with a region showing loss of
heterozygosity, which was located on chromosome X and
included a deletion of the XIC (figure 1). No other copy
number changes were identified (electronic supplementary
material, figure S1).
The centromeric breakpoint of the identified deletion was
located in a 148 kb long segment between SNPs rs6650032
and rs6650032. This region is characterized by a large
inverted segmental duplication, including DMRTC1 and
DMRTC1b, complicating the precise mapping of this break-
point (figure 2a). The location of this breakpoint determines
if the duplication is intact and present as two copies of
DMRTC1 and DMRTC1b, or partially deleted and conse-
quently present as a single copy of DMRTC1 on the
affected X chromosome. The telomeric breakpoint of this
region was located in a 17 kb region, delineated by SNPs
rs12688161 and rs5981589. A deletion encompassing the
XIC and as small as this, has not been reported before,
which prompted us to study this deletion in detail. To charac-
terize the breakpoint regions more precisely we performed
qPCR to determine the copy number at consecutive positions
along the breakpoint regions. As a control, DNA from a
healthy female and a healthy male was used. qPCR analysis
along the centromeric breakpoint region, detected two copies
centromeric of the inverted duplication in this region, and
one copy telomeric. Three qPCR amplicons within the dupli-
cation all indicated the presence of 1.5 copies, suggesting the
breakpoint is located in the middle of the inverted dupli-
cation (figure 2b). To map the deletion at the single
nucleotide level, targeted locus amplification (TLA) was per-
formed on frozen lymphoblastoid cells. TLA technology
entails sequencing of all sequences that occur in physical
proximity to a primer pair used for targeted amplification.
Using this technology, with primer sets located on the telo-
meric side of the deletion, we found an increase in coverage
in the centre of the inverted duplication, indicating the pos-
ition of the centromeric breakpoint (figure 3a,b). Among the
obtained reads the break-spanning read was also identi-
fied (figure 3c). The flanking sequence of the centromeric
breakpoint maps to both duplicons of the inverted dupli-
cation, but the orientation of the sequence corresponds
to the centromeric duplicon. This maps the deletion to
ChrX: 72.080.568–73.367.054 (hg19), a region of 1.28 Mb,
and among the genes involved in the deletion are XIST,
TSIX and other cis-regulatory genes and elements in XCI
(electronic supplementary material, table S1).
The deletion was confirmed by DNA-FISH, using several
BACs mapping to different regions of the X chromosome.
DNA-FISH using BACs containing PHKA2 or RNF12 con-
firmed the presence of two X chromosomes in all nuclei,
while DNA-FISH using BACS covering XIST or JPX indicated
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Figure 1. XIC deletion identified by SNP array analysis. (a) SNP array analysis showing chromosome X with the XIC deletion. At the top a schematic representation of
the X chromosome is shown with the deletion indicated in red. Below the results of the SNP array analysis are shown. Every dot is representing a probe along the X
chromosome. The upper panel shows the deleted area in red. The lower panel shows SNP array data revealing loss of heterozygosity for several regions on the X, of
which one overlaps with the deleted sequence (areas marked in yellow, with B allele frequency (BAF) of 100% or 0%). (b) A magnification of the region encom-
passing the XIC. At the top a schematic representation of the region is shown, with the genes located in this region below. The deletion is indicated in red. Panels
are similar to those in (a).
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(figure 4a). XCIwas analysed byXISTRNA-FISHon cells froma
lymphoblastoid cell line of the patient. All examined cells con-
tained an XIST RNA cloud, indicating XCI is initiated in cells
with the 1.28 Mb deletion (figure 4b). To assess the XIR, allele
specific methylation analysis of fragile X mental retardation 1
(FMR1), onDNA isolated fromperipheral blood, showedpredo-
minant inactivation of one allele (93 : 7%), indicating that XCI is
severely skewed in the patient (data not shown). To determine
which X chromosome was inactivated, sequential DNA-RNA
FISHwas performed forXISTRNA and the JPX locus, included
in the deletion. XIST RNA domains co-localized with the JPX
locus of the unaffected X chromosome in most cells, confirming
near complete skewing towards inactivation of the unaffected X
chromosome (figure 4b).
3. Discussion
Here we identified a patient with a deletion encompassing
the human XIC. Our results demonstrate that in the presence
of the identified 1.28 Mb deletion, XCI can still occur on the
unaffected X chromosome. Therefore, the region involved in
the deletion, extending from FTX to the first duplicon of
DMRTC1, does not affect trans-regulation of XCI, but most
likely covers most elements and genes involved in cis-regu-
lation of human XCI. The identified deletion, and the
absence of an X-inactivation phenotype resemble the DXTX
and D(Xite-Dxmit171) deletions that were studied in
mouse embryonic stem (ES) cells [16,17]. The DXTXdeletion involves only Xist, Tsix and Xite, whereas the
D(Xite-Dxmit171) deletion also includes the neighbouring
regulators Jpx and Ftx. ES cells with heterozygous DXTX
and D(Xite-Dxmit171) deletions, inactivate the wild-type
X chromosome, indicating that all trans-acting factors are
still present. These results and the human deletion presented
here indicate that JPX, and other sequences including TSIX,
previously implicated in trans-regulation of XCI, through
X-pairing and RNA mediated recruitment mechanisms, are
not required to properly initiate the human XCI process
in-trans [13,21].
Whether the deletion described here represents the entire
cis-acting XIC remains elusive. This human cis-XIC is most
likely delineated by the topologically associating domain(s)
(TAD) in which XIST resides. TADs were identified by studies
examining the higher order chromatin structure, indicating
limitation of spatial interactions to cis domains of approxi-
mately 1 Mb in size [15,22]. Analysis of available data on
TADs in human H1 male ES cells and IMR90 female fibro-
blasts, indicates that the human XIC of H1 ES cells is
included in a single large TAD, ranging from DMRTC1 to
RNF12, not including RNF12 [22]. In human IMR90 fibro-
blasts containing an Xi, this region is divided into two
smaller TADs with the boundary at the XIST/TSIX locus
which now includes RNF12, similar to mouse (figure 5).
This change in higher order topology might be instructive
in or the consequence of XCI and considering these data,
the human XIC might extend beyond the studied deletion
from DMRTC1 to FTX, and might include RNF12.
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Figure 2. XIC deletion identified PCR. (a) The XIC deletion as identified by comparative genomic hybridization (CGH). A schematic representation of the X-chromosome
is shown, with the deleted region marked in red. (b) Comparison of qPCR results to CGH. A magnification is shown of the regions containing the breakpoints. The top
panel shows qPCR results along the breakpoint regions, with copy number plotted against chromosomal position. In the map of the chromosomal region below, the
inverted duplication in the centromeric breakpoint region is marked in blue.
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Figure 3. XIC deletion identified by TLA. (a) TLA coverage is plotted against chromosomal position. Arrow indicates the location of the primer sets. Star indicates the
increase in coverage on the other side of the deleted region. A genetic map of the region is shown below, with the inverted duplication in blue. (b) Magnification of
the centromeric breakpoint region. (c) The break-spanning read, with the sequence centromeric of the breakpoint marked in blue and the sequence telomeric of the
breakpoint marked in green.
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etion does not include important trans-acting factors.
Although the identity of these factors remains elusive so
far, our results are compatible with a role for human
RNF12 in trans-activation of human XCI, as RNF12 is not
included in the deletion and still present on both X chromo-
somes of the female individual described here (figure 3a). A
role for RNF12 in human XCI is further supported by a
recent finding that female carriers of a mutation in RNF12
show exclusive XCI of the mutated X [23]. Skewed XCI
could be the consequence of cell selection processes, butmale carriers with the same mutation are born only display-
ing X-linked intellectual disability, which might implicate a
direct involvement of RNF12 in XCI. This finding is also con-
cordant with mouse studies which show that one functional
copy of Rnf12 is required for establishment of the inactive X
chromosome [16]. The XIC deletion identified here is compar-
able to the region described to represent the human XIC,
which was defined by genetic studies involving large X chro-
mosomal abnormalities resulting from truncations and
translocations. At first the XIC was delineated by an X;14
translocation in an XXY male and the breakpoint of an
H13
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Figure 4. The X-chromosome carrying the deletion is preferentially active. (a) At the top, a map of the X-chromosome is shown with the location of the BAC probes
that were used indicated in blue. The location of the deletion as identified by CGH and TLA is marked in red. Below, representative images of DNA-FISH for regions
located inside or outside the deleted region are shown. BAC CTD-2310H21, containing PHKA2, and BAC CTD 2530H13, containing RNF12, are located outside the
deleted region. BAC CTD-2183M22, containing XIST, and BAC RP13-36G14, containing JPX, are located within the deleted region. Results from analysing at least 30
metaphases are shown in the tables to the right. (b) Representative pictures of sequential RNA-DNA-FISH. Two representative nuclei are shown with RNA-FISH results
for XIST RNA in green, and DNA-FISH results for BAC RP13-36G14 in yellow and BAC CTD-2310H21 in red. The table to the right shows the percentage of nuclei with
overlapping signals of XIST RNA and BAC RP13-36G14 DNA.
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rearrangements the XIC was estimated to measure at least
0.8 Mb in size with a maximum of 2.89 Mb (figure 5). Later
the telomeric boundary was redefined by studies involving
another rearranged X chromosome (rea(X)), reducing the esti-
mated size of the XIC to 0.68–1.2 Mb [6]. In all these
individuals XCI is still initiated, leading to inactivation of
the X;14 translocation product, or the mutated idic(X) and
rea(X) X chromosomes, demonstrating the presence of suffi-
cient levels of XCI activators for initiation of XCI.
Interestingly, the rea(X) does not contain an intact copy ofRNF12. These results demonstrate that either RNF12 does
not function as a trans-acting activator, or that other
human trans-acting activators exist next to RNF12 and are
located on the proportion of the X chromosome not deleted
from rea(X). In support of this latter hypothesis, mouse
studies also hinted at the presence of additional XCI activa-
tors besides Rnf12, as ES cells carrying a heterozygous Rnf12
deletion still initiate XCI, although at a reduced frequency
[18,19,25]. Although our results suggest RNF12 is a trans-
acting activator of human XCI and are concordant with
mouse studies, further investigation is required.
XIST
TSIXCHIC1NAP1L2
DMRTC1
DMRTC1
PHKA1HDAC1
CITED1
FTX RLIM
ZDHCC15
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t(X;14)
H1 male
hESC
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fibroblasts
DXIC
(a)
(b)
Figure 5. Deletions delineating the human XIC. (a) Graph of the chromosomal abnormalities studied to define the XIC. Black bars indicate the sequence present on
the abnormal X-chromosome. From top to bottom: the rea(X) of female S.A., the idic(Xp) of female A.G., the X;14 translocation chromosome from a 47XXY male, the
XIC deletion reported here. Below a map of the X-chromosomal region Xq13, containing the XIC is shown. (b) The topological domain structure of the XIC as
identified in female IMR90 fibroblasts and male H1 human ES cells.
DMRTC1 DMRTC1b XIST
DMRTC1 DMRTC1b XIST
(a)
(b)
Figure 6. In-cis deletion of the cis-XIC and DMRTC1 results in DMRTC1 dose
deficiency. (a) Normal situation: a schematic representation of two X chromo-
somes after X-inactivation is shown. Two copies of DMRTC1 remain active.
(b) In-cis deletion of the XIC and DMRTC1: as a result of the deletion the
unaffected X chromosome is preferentially inactivated, and only one copy
of DMRTC1 remains active.
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ian dysgenesis. As our results indicate complete skewing of
XCI, with the affected X chromosome remaining active, the
deletion itself might be involved in ovarian dysgenesis.
Prior work has also implicated chromosome Xq13, harbour-
ing the XIC, in amenorrhoea, as several cases have been
described with a breakpoint in this region and primary amen-
orrhoea and various signs of Turner syndrome [26].
Hypothesizing that one of the genes in the identified deletion
is responsible for the ovarian dysgenesis phenotype, we
assessed all involved genes by gene ontology (GO) analysis
using the AmiGO 2 browser. GO terms involved in gonadal
functioning or gonadal development, revealed one candidate
gene: DMRT-like family C1 (DMRTC1), implicated in sex
differentiation, and included in the 1.28 Mb deletion studied
here. Little is known about DMRTC1 itself. It is part of the
Doublesex and Mab-3 Related Transcription factor (DMRT)
gene family, involved in sex-determination in vertebrates.
DMRT1 has been extensively studied, and loss of one copy
of human DMRT1 results in defective testicular development
and XY male-to-female sex reversal. No studies regarding
DMRTC1 functioning in human are published. However, ofthe three mouse homologues of DMRTC1, Dmrt8.3 is
expressed in XX germ cells of the embryonic ovary, from
embryonic day 13.5 onwards, suggesting involvement in
meiosis [27]. Taken together, a role for DMRTC1 in ovarian
development is likely, and it can be hypothesized that the
deletion of one of the two copies present on the X chromo-
some causes ovarian dysgenesis in the individual described
here. XCI is 100% skewed and as a result cells carrying the
XIC deletion will contain only one active copy of DMRTC1/
DMRTC1b instead of two, which might result in a dosage
deficiency for DMRTC1/DMRTC1b (figure 6), leading to ovar-
ian dysgenesis. Interestingly, functional loss of other protein
coding genes, including CDX4 and CHIC1 appears well toler-
ated, which might be explained by redundant mechanisms, as
reported for Cdx4 in mice, or escape of XCI.
In summary, our studies show that XCI is normally
initiated in a female carrier with a 1.28 Mb deletion of the
XIC, and indicate that the trans-acting information required
for female specific initiation of XCI is located outside the
identified deletion. Our findings highlight the evolutionary
conservation of pathways and mechanisms involved in
regulation of XCI in eutherians.4. Material and methods
(a) Targeted locus amplification
Cross-linked chromatin, was fragmented and re-ligated, and two
sets of primer pairs were designed for the sequence telomeric of
the deletion, and used in individual TLA amplifications accord-
ing to de Vree et al. [28]. PCR products were purified and pooled,
prepared for sequencing using the Illumina NexteraXT protocol,
and sequenced on an Illumina Miseq sequencer. Reads were
mapped using a BWA-SW algorithm allowing partial mapping.
In case of a deletion, existing interactions with the deleted
region are abolished and new interactions with the new
neighbouring sequence are produced.
(b) DNA-FISH
Cells were arrested in metaphase using colcemid for 2 h, treated
with 0.075 M KCl, and fixed with methanol/acetic acid. Slides
were dehydrated, denatured and incubated with probe mixture
as described in [18]. Probes, indicated in figure 4a, were detected
with a FITC conjugated mouse-anti-digoxigenin antibody or
rstb.royalsocietypublishing.org
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identified in DAPI and subsequently the number of red and
green foci were counted.
(c) DNA-RNA-FISH
Cytospin preparations were prepared and cells were fixed with
4% PFA, and RNA-FISH was performed as described before
[17]. Cells were analysed for presence of an XIST RNA cloud
and photographs were taken. Subsequently slides were subjected
to DNA-FISH. Cells were denatured and incubated with probe
mixture and detected with a FITC conjugated mouse-anti-digoxi-
genin antibody or Alexa 594 conjugated streptavidin. Cells
analysed for RNA-FISH were re-analysed for a DNA-FISH
signal. Pictures from DNA-FISH and RNA-FISH were overlaid
and scored for co-localization of signals.
(d) RT-PCR
Quantitative RT-PCR was performed using Platinum Taq
DNA polymerase (Life Technologies), SYBR green (Sigma
Aldrich) according to the manufacturer’s instructions. Primer
sets and their chromosomal locations are listed in electronic
supplementary material, Methods 1.
(e) SNP and CNV detection
Molecular SNP karyotyping was performed on a Human
OmniExpress-24 SNP-array (Illumina). Data analysis was per-
formed with the BioDiscovery’s SNP-FASST2 segmentationalgorithm, an extension of the FASST2 segmentation algorithm
(a hidden Markov model [HMM] based approach). B-allele fre-
quency probes were assigned to a range of possible states and
a combination of the BAF and log-R states were used to make
the final copy number and allelic event calls. The significance
threshold for segmentation was set at 51029 also requiring a
minimum of eight probes per segment and a maximum probe
spacing of 1000 kb between adjacent probes before breaking a
segment. The log ratio thresholds for single copy gain and
single copy loss were set at 0.25 and 20.2, respectively. The
homozygous frequency threshold was set to 0.85. The homozy-
gous value threshold was set to 0.8. The heterozygous
imbalance threshold was set to 0.4. The minimum loss of
heterozygosity length was set at 300 kb.
Ethics. The participant was recruited through the Childhood Over-
growth (COG) Study, which began recruitment in 2005, approved
by the London Multicenter Ethics Committee (05/MRE02/17).
Informed consent was obtained from all participants.
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